Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series

J Am Acad Dermatol. 2020 Jun;82(6):1539-1542. doi: 10.1016/j.jaad.2020.02.050. Epub 2020 Feb 21.

Authors

Christina Wong¹, Christine Poblete-Lopez², Allison Vidimos²

Affiliations

¹ Department of Dermatology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Electronic address: [email protected].
² Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.

PMID: 32092372
DOI: 10.1016/j.jaad.2020.02.050

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Anilides / administration & dosage*
Basal Cell Nevus Syndrome / drug therapy*
Basal Cell Nevus Syndrome / pathology
Carcinoma, Basal Cell / drug therapy*
Carcinoma, Basal Cell / pathology
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Neoplasm Staging
Pyridines / administration & dosage*
Retrospective Studies
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Young Adult

Substances

Anilides
HhAntag691
Pyridines